Merck KGaA’s ATR inhibitor cancer drug has been cleared for further clinical trials after it showed encouraging activity in a phase 1 study. Short for ataxia telangiectasia and Rad3-related kinase, ...
Exploration, evaluation and project work through Astron Pty Limited and Donald Mineral Sands Pty Limited, The operation of titanium-based materials processing activities and The evaluation and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback